Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy

Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy

Background: Nucleos(t)ide analogues (NUCs) were proved to reduce hepatocellular carcinoma (HCC) development in chronic hepatitis B (CHB) patients, but data were limited on their efficacy in cirrhotic CHB patients. Methods: A total of 447 cirrhotic CHB patients treated with tenofovir/entecavir were r...

Full description

Bibliographic Details
Main Authors: Yuh-Ying Liu, Chih-Lang Lin, Cheng-Hao Weng, Pei-Hung Chang, Cheng-Hung Chien, Kuang-Chen Huang, Man-Chin Hua, Ching-Chih Hu
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Diagnostics
Subjects:
chronic hepatitis B
cirrhosis
cumulative incidence
incidence rate
risk
hepatocellular carcinoma
Online Access:https://www.mdpi.com/2075-4418/12/9/2085

Internet

https://www.mdpi.com/2075-4418/12/9/2085

Similar Items